
Welcure Drugs And Pharmaceuticals Limited
Manufactures, distributes, and sells water processing equipment and purifiers.
Manufactures, distributes, and sells water processing equipment and purifiers.
Welcure Drugs And Pharmaceuticals Limited (WDAPL) is a Public Limited Indian Non-Government Company incorporated in India on 06 August 1996 and has a history of 28 years and seven months. Its registered office is in North West Delhi, Delhi, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524661.
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 116.00 Cr and a paid-up capital of Rs 13.44 Cr.
The company has closed loans amounting to ₹22.08 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Welcure Drugs And Pharmaceuticals Limited India are Altaf Shah as CFO and Manowar Ali as Company Secretary. Ashish Abbi, Suraj Solanki, Altaf Shah, and One other member serve as directors at the Company.
North West Delhi, Delhi, India
+91-XXXXXXXXXX
L24232DL1996PLC227773
227773
BSE : 524661
Public Limited Indian Non-Government Company
06 Aug 1996
28 Sep 2023
31 Mar 2023
Listed
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Altaf Shah | CFO | 29-Feb-2024 | Current |
Manowar Ali | Company Secretary | 22-Oct-2022 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ashish Abbi ![]() | Director | 22-May-2024 | Current |
Suraj Solanki ![]() | Additional Director | Current | |
Deepika Iyer ![]() | Director | 29-Feb-2024 | Current |
Welcure Drugs And Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 125.85% increase. The company also saw a substantial improvement in profitability, with a 331.41% increase in profit. The company's net worth Soared by an impressive increase of 1529.22%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2022, Welcure Drugs And Pharmaceuticals had a promoter holding of 14.12% and a public holding of 85.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹0
₹22.08 Cr
Date | Lender | Amount | Status |
---|---|---|---|
28 Sep 2004 | State Bank Of India | ₹3.68 Cr | Satisfied |
30 Aug 2004 | State Bank Of India | ₹18.40 Cr | Satisfied |
Unlock and access historical data on people associated with Welcure Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Welcure Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Welcure Drugs And Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ashish Abbi was appointed as a Director was appointed as a Director on 22 May 2024 & has been associated with this company since 10 months 8 days .
Altaf Hussain Shah was appointed as a Cfo was appointed as a Cfo on 29 Feb 2024 & has been associated with this company since 1 year 30 days .
Deepika Krishnan Iyer was appointed as a Director was appointed as a Director on 29 Feb 2024 & has been associated with this company since 1 year 30 days .
Welcure Drugs And Pharmaceuticals Limited last Annual general meeting of members was held on 28 Sep 2023 as per latest MCA records.
Welcure Drugs And Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
Manowar Ali was appointed as a Company Secretary was appointed as a Company Secretary on 22 Oct 2022 & has been associated with this company since 2 years 5 months .
Welcure Drugs And Pharmaceuticals Limited was incorporated on 06 Aug 1996.
The authorized share capital of Welcure Drugs And Pharmaceuticals Limited is ₹ 116.00 Cr and paid-up capital is ₹ 13.44 Cr.
Currently 6 directors are associated with Welcure Drugs And Pharmaceuticals Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Welcure Drugs And Pharmaceuticals Limited is B-9& 10 Laxmi Towers, Lsc C-Block Saraswati Vihar, Delhi, India, 110034.
The corporate identification number (CIN) of Welcure Drugs And Pharmaceuticals Limited is L24232DL1996PLC227773 and the company number is 227773 as per Ministry of Corporate Affairs (MCA).
Yes, Welcure Drugs And Pharmaceuticals Limited is registered on Bombay Stock Exchange (BSE).
According to the financial reports for the fiscal year 2023, the revenue trend for Welcure Drugs And Pharmaceuticals Limited has risen by 125.85%.
The financial reports for the fiscal year 2023 indicates that The net worth of Welcure Drugs And Pharmaceuticals Limited has experienced an upsurge of 1529.22%.
The most recent Balance Sheet for Welcure Drugs And Pharmaceuticals Limited was filed with the ROC on 31 Mar 2023.
RP
DJ
SJ
SJ